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a  b  s  t  r  a  c  t
Aortic  thrombosis  is  rare, especially  in  non-atherosclerotic  aortae.  A  51-year-old  woman  presented  with
intermittent  claudication  in  the right  lower  extremity.  She  was  diagnosed  as  having  peripheral  artery  dis-
ease  on  ultrasound.  A  computed  tomography  scan  showed  a  large, sessile,  aortic  mural  thrombus  from  the
infrarenal  abdominal  aorta  to the  right  common  iliac  artery. An  arteriogram  showed  an  abrupt  occlusion
of  the  right  superﬁcial  femoral  artery  with  collateral  arteries.  She  had  no  risk  factors  for  atherosclero-
sis.  Interestingly,  this  occurred  before  early  esophageal  cancer  progressed.  Heparin  was  administered
intravenously  and  later  changed  to warfarin.  In  the  follow-up  period,  the  thrombus  disappeared,  and
her  symptoms  improved.  A careful  investigation  for malignant  disease  is needed  when  aortic  thrombuseripheral artery disease occurs  in  patients  with  no atherosclerosis  risk  factors.
<Learning  objective:  Aortic  thrombosis  is rare, especially  in  non-atherosclerotic  aortae.  A  patient  who
presented  with  descending  aortic  thrombosis  and  peripheral  embolism  complicating  early  esophageal
carcinoma  is presented.  Interestingly,  this  occurred  before  the cancer  progressed.  A  careful  investigation
for malignant  disease  is needed  when  aortic  thrombus  occurs  in  patients  with  no  atherosclerosis  risk
3  Jap
factors.>
© 201
ntroduction
Venous thromboembolism is a frequent complication in can-
er patients. Aortic thromboembolism is, however, extremely rare
ven in cancer patients. A case of descending aortic thrombosis and
istal embolism preceding the progression of early esophageal car-
inoma is reported. To the best of our knowledge, this is the ﬁrst
eport of aortic thrombosis complicating early-stage cancer.
ase report
A 51-year-old Japanese woman presented with intermittent
laudication (Fontaine IIa) in the right lower extremity. This symp-
om appeared and gradually worsened over 2 months prior to
dmission. She initially consulted an orthopedist and was  diag-
osed as having peripheral artery disease on ultrasound. She was
eferred for cardiology consultation. She had no risk factors for
therosclerosis. Her medical history revealed that she had under-
one a gastrectomy for gastric cancer at the age of 42 years, and she
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was diagnosed as having early esophageal cancer one and half years
earlier. The esophageal cancer was localized in situ at the cervical
portion; the pathological diagnosis was  squamous cell carcinoma
in situ. Lymph node and other organ metastases were ruled out on
imaging studies, and the clinical stage was  determined to be early
esophageal cancer. Because she rejected surgery, combination ther-
apy including radiotherapy and chemotherapy with ﬂuorouracil (5-
FU) was performed until she attended the cardiology consultation.
Physical examination revealed that her right popliteal artery
was not palpable, and her right calf was cold and pale, although
the other extremities looked normal. The ankle to brachial pres-
sure index was  0.74 on the right and 1.04 on the left. Laboratory
examinations revealed a normal hemogram except for mild iron
deﬁciency anemia (hemoglobin: 8.1 g/dl, mean corpuscular vol-
ume: 74.7 ﬂ, ferritin: 3.2 ng/ml). Serum tests for hepatitis B and
C viruses and syphilis were negative, and the activities of pro-
tein C and S were within normal limits. Auto-antibodies against
nuclear antigen, double-stranded DNA, cardiolipin, and neutrophil
cytoplasmic antigens were all negative. Prothrombin time, acti-
vated partial thromboplastin time, and ﬁbrinogen concentration
were normal. Only her D-dimer was  elevated to 5.25 g/ml, which
suggested the possibility of thrombosis. On ultrasound examina-
tion, there was no evidence of deep vein thrombosis or intracardiac
thrombus.
vier Ltd. All rights reserved.
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Fig. 1. (A) Enhanced spiral computed tomography demonstrating a primary aortic mural thrombus (arrow). (B) Angiography demonstrating an abrupt occlusion of the right
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3uperﬁcial femoral artery (arrow).
A computed tomography (CT) scan showed a large, sessile, aor-
ic mural thrombus from the infrarenal abdominal aorta to the
ight common iliac artery (Fig. 1A), which was not recognized on
he CT three months earlier. The previous radiation therapy was
ot considered to have reached near or to the nidus of the aortic
hrombus. When hospitalized, she felt pain in her right great toe
ven at rest. Magnetic resonance imaging showed normal thick-
ess and regular margin, suggesting no inﬂammatory changes in
he vessel wall. There was no evidence of underlying atheroscle-
otic disease in the aorta on these imaging studies. An arteriogram
howed an abrupt occlusion of the right superﬁcial femoral artery
ith collateral arteries (Fig. 1B).
Heparin was administered intravenously and later changed to
arfarin. A vascular surgery team was consulted, and it was  decided
o continue conservative therapy. One month later, the throm-
us was dramatically decreased at CT imaging, and her symptoms
mproved.
On discharge, the endoscopy study showed that the esophageal
ucosa was clear, and the pathological samples had no malig-
ancy. Combination therapy was restarted for cancer, and she had
o complaints for 6 months. However, endoscopy and biopsy exam-
nation revealed progression and recurrence of esophageal cancer
t that time, with pathological evidence of high-grade neoplasia.
ndoscopic submucosal dissection was performed safely, and she
as discharged well. Interestingly, the latest systemic CT image,
 months after starting anticoagulation therapy, conﬁrmed thatthe aortic thrombus and distal artery obstruction had disappeared
completely.
Discussion
A peripheral arterial emboligenic source can be identiﬁed
in about 90% of patients on noninvasive imaging examinations.
Around 85% of them originate in the heart. It has been estimated
that 5% of embolisms originate in the aorta [1]. Aortic thrombosis
is relatively common among patients with severe atherosclerosis,
aneurysm, cardiovascular surgery, trauma, uncontrolled diabetes
mellitus, active tuberculosis, and aortitis [1–3]. Aortic thrombo-
sis is rare, however, in an apparently healthy vascular segment.
In these cases, aortic thrombosis may  be related to identiﬁable
hypercoagulable states or to factors predisposing to the formation
of clots, such as sepsis, polycythemia, disseminated intravascular
coagulation, autoimmune disease, and myeloid leukemia [2–4]. A
hypercoagulable state related to cancer is a well-known risk factor
for venous thrombosis [5]. On the other hand, there are fewer data
on arterial thrombosis than for venous thrombosis. Nevertheless,
thrombosis in arteries has long been recognized [6,7]. Although
the correct mechanisms remain unclear, it is known that tumor
cells are directly prothrombotic and normal host cells may  be
also as a second response against the cancer cells [7]. Additionally
increased levels of coagulation factors, blood turbulence, coex-
isting inﬂammatory diseases, use of growth factors, chemotherapy,
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nd irradiation therapy may  all induce thrombosis. One possi-
le mechanism is endothelial damage with the loss of its natural
nticoagulant nature and acquisition of a procoagulant proﬁle [7].
he current case is a rare case of aortic thrombosis complicating
sophageal cancer in a patient 1 year and 4 months after radiation
nd chemotherapy without apparent recurrence and metastasis.
There is a general consensus that these patients should receive
nticoagulation therapy [2]. Surgical thrombectomy should be
erformed for selected cases of recurrent embolism or persis-
ent thrombus despite proper anticoagulation. Patients with a
hreatened extremity should undergo emergency surgical revas-
ularization to resolve the symptoms of acute distal embolization,
n addition to perioperative intravenous heparin therapy with con-
ersion to oral anticoagulation, so that primary aortic ﬁbrinolysis
an occur. Indeed, anticoagulant therapy decreased the size of the
ortic thrombus in the present case.
The risk of thrombosis due to cancer is compounded by the
ffects of chemotherapy and other treatments. Since the patient
ad received 5-FU treatment when complaining of intermittent
laudication, a possible effect of chemotherapy on the occur-
ence of her arterial thrombosis cannot be completely excluded.
owever, no case of aortic thrombosis in a patient with even
dvanced esophageal cancer with or without chemotherapy has
een reported. To the best of our knowledge, this is the ﬁrst report of
[
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aortic thrombosis complicating esophageal carcinoma. The clinical
stage was  considered to be early cancer. Interestingly, progression
of the cancer was not noted until 6 months after the aortic throm-
bus was found, suggesting that the hypercoagulable state may  have
been caused by the proliferative activity of the cancer.
In conclusion, a thorough evaluation for malignant disease
should be performed in patients with an aortic thrombus and
embolism in non-atherosclerotic aortae.
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